<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37460909</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1568-5608</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Inflammopharmacology</Title><ISOAbbreviation>Inflammopharmacology</ISOAbbreviation></Journal><ArticleTitle>Multisystem inflammatory syndrome in children (MIS-C): Implications for long COVID.</ArticleTitle><Pagination><StartPage>2221</StartPage><EndPage>2236</EndPage><MedlinePgn>2221-2236</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10787-023-01272-3</ELocationID><Abstract><AbstractText>The COVID-19 pandemic caused by the coronavirus 2 of the severe acute respiratory syndrome (SARS-CoV-2) has significantly affected people around the world, leading to substantial morbidity and mortality. Although the pandemic has affected people of all ages, there is increasing evidence that children are less susceptible to SARS-CoV-2 infection and are more likely to experience milder symptoms than adults. However, children with COVID-19 can still develop serious complications, such as multisystem inflammatory syndrome in children (MIS-C). This narrative review of the literature provides an overview of the epidemiology and immune pathology of SARS-CoV-2 infection and MIS-C in children. The review also examines the genetics of COVID-19 and MIS-C in children, including the genetic factors that can influence the susceptibility and severity of the diseases and their implications for personalized medicine and vaccination strategies. By examining current evidence and insights from the literature, this review aims to contribute to the development of effective prevention and treatment strategies for COVID-19, MIS-C, and long COVID syndromes in children.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Constantin</LastName><ForeName>Tam&#xe1;s</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-9291-295X</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Semmelweis University, T&#x171;zolt&#xf3; u. 7-9., Budapest, 1094, Hungary. tamas.constantin@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;k</LastName><ForeName>Tam&#xe1;s</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Semmelweis University, T&#x171;zolt&#xf3; u. 7-9., Budapest, 1094, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horv&#xe1;th</LastName><ForeName>Zsuzsanna</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Semmelweis University, T&#x171;zolt&#xf3; u. 7-9., Budapest, 1094, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garan</LastName><ForeName>Di&#xe1;na</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Semmelweis University, T&#x171;zolt&#xf3; u. 7-9., Budapest, 1094, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szab&#xf3;</LastName><ForeName>Attila J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Semmelweis University, T&#x171;zolt&#xf3; u. 7-9., Budapest, 1094, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Inflammopharmacology</MedlineTA><NlmUniqueID>9112626</NlmUniqueID><ISSNLinking>0925-4692</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000705967">pediatric multisystem inflammatory disease, COVID-19 related</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID</Keyword><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">MIS-C</Keyword></KeywordList><CoiStatement>A conflict of interest declaration is mandatory for publication in this journal. Please confirm that this declaration is accurate, or provide an alternative</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>18</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37460909</ArticleId><ArticleId IdType="pmc">PMC10518292</ArticleId><ArticleId IdType="doi">10.1007/s10787-023-01272-3</ArticleId><ArticleId IdType="pii">10.1007/s10787-023-01272-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akbil B, Meyer T, Stubbemann P, et al. Early and rapid identification of COVID-19 patients with neutralizing type I-interferon auto-antibodies by an easily implementable algorithm. Medrxiv. 2021 doi: 10.1101/2021.11.12.21266249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.12.21266249</ArticleId><ArticleId IdType="pmc">PMC9069123</ArticleId><ArticleId IdType="pubmed">35511314</ArticleId></ArticleIdList></Reference><Reference><Citation>Akindele NP, Pieterse L, Suwanmanee S, Griffin DE. B cell responses in hospitalized SARS-CoV-2-infected children with and without multisystem inflammatory syndrome. J Infect Dis. 2022 doi: 10.1093/infdis/jiac119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac119</ArticleId><ArticleId IdType="pmc">PMC9047220</ArticleId><ArticleId IdType="pubmed">35436340</ArticleId></ArticleIdList></Reference><Reference><Citation>Arostegui D, Castro K, Schwarz S, et al. Persistent SARS-CoV-2 nucleocapsid protein presence in the intestinal epithelium of a pediatric patient 3 months after acute infection. Jpgn Reports. 2021;3:e152. doi: 10.1097/pg9.0000000000000152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/pg9.0000000000000152</ArticleId><ArticleId IdType="pmc">PMC10158423</ArticleId><ArticleId IdType="pubmed">37168753</ArticleId></ArticleIdList></Reference><Reference><Citation>Asano T, Boisson B, Onodi F, et al. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci Immunol. 2021;6:eabl4348. doi: 10.1126/sciimmunol.abl4348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abl4348</ArticleId><ArticleId IdType="pmc">PMC8532080</ArticleId><ArticleId IdType="pubmed">34413140</ArticleId></ArticleIdList></Reference><Reference><Citation>Bami S, Vagrecha A, Soberman D, et al. The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2020;67:e28581. doi: 10.1002/pbc.28581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pbc.28581</ArticleId><ArticleId IdType="pubmed">32725881</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585. doi: 10.1126/science.abd4585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Gervais A, Voyer TL, et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021;6:eabl4340. doi: 10.1126/sciimmunol.abl4340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abl4340</ArticleId><ArticleId IdType="pmc">PMC8521484</ArticleId><ArticleId IdType="pubmed">34413139</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Vazquez S, Liu J, et al. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs. Sci Immunol. 2022 doi: 10.1126/sciimmunol.abp8966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abp8966</ArticleId><ArticleId IdType="pmc">PMC9210448</ArticleId><ArticleId IdType="pubmed">35857576</ArticleId></ArticleIdList></Reference><Reference><Citation>Beccuti G, Ghizzoni L, Cambria V, et al. A COVID-19 pneumonia case report of autoimmune polyendocrine syndrome type 1 in Lombardy, Italy: letter to the editor. J Endocrinol Invest. 2020;43:1175&#x2013;1177. doi: 10.1007/s40618-020-01323-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01323-4</ArticleId><ArticleId IdType="pmc">PMC7282538</ArticleId><ArticleId IdType="pubmed">32519200</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck A, Gandhi M. Adjudicating reasons for hospitalization reveals that severe illness from COVID-19 in children is rare. Hosp Pediatrics. 2021;11:e159&#x2013;e160. doi: 10.1542/hpeds.2021-006084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/hpeds.2021-006084</ArticleId><ArticleId IdType="pmc">PMC9492297</ArticleId><ArticleId IdType="pubmed">34011568</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckmann ND, Comella PH, Cheng E, et al. Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children. Nat Commun. 2021;12:4854. doi: 10.1038/s41467-021-24981-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24981-1</ArticleId><ArticleId IdType="pmc">PMC8357784</ArticleId><ArticleId IdType="pubmed">34381049</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg SK, Nielsen SD, Nygaard U, et al. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc Health. 2022;6:240&#x2013;248. doi: 10.1016/s2352-4642(22)00004-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2352-4642(22)00004-9</ArticleId><ArticleId IdType="pmc">PMC8820960</ArticleId><ArticleId IdType="pubmed">35143771</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhopal SS, Bagaria J, Olabi B, Bhopal R. Children and young people remain at low risk of COVID-19 mortality. Lancet Child Adolesc Heal. 2021;5:e12&#x2013;e13. doi: 10.1016/s2352-4642(21)00066-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2352-4642(21)00066-3</ArticleId><ArticleId IdType="pmc">PMC7946566</ArticleId><ArticleId IdType="pubmed">33713603</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L, Holm M, Knudsen M, et al. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur J Pediatr. 2022;181:1597&#x2013;1607. doi: 10.1007/s00431-021-04345-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Buszko M, Nita-Lazar A, Park J-H, et al. Lessons learned: new insights on the role of cytokines in COVID-19. Nat Immunol. 2021;22:404&#x2013;411. doi: 10.1038/s41590-021-00901-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00901-9</ArticleId><ArticleId IdType="pmc">PMC9317654</ArticleId><ArticleId IdType="pubmed">33723418</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M-R, Kuo H-C, Lee Y-J, et al. Phenotype, susceptibility, autoimmunity, and immunotherapy between kawasaki disease and coronavirus disease-19 associated multisystem inflammatory syndrome in children. Front Immunol. 2021;12:632890. doi: 10.3389/fimmu.2021.632890.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.632890</ArticleId><ArticleId IdType="pmc">PMC7959769</ArticleId><ArticleId IdType="pubmed">33732254</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng MH, Zhang S, Porritt RA, et al. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proc Natl Acad Sci. 2020;117:25254&#x2013;25262. doi: 10.1073/pnas.2010722117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2010722117</ArticleId><ArticleId IdType="pmc">PMC7568239</ArticleId><ArticleId IdType="pubmed">32989130</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JH, Choi S-H, Yun KW. Risk factors for severe COVID-19 in children: a systematic review and meta-analysis. J Korean Med Sci. 2022 doi: 10.3346/jkms.2022.37.e35.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2022.37.e35</ArticleId><ArticleId IdType="pmc">PMC8822112</ArticleId><ArticleId IdType="pubmed">35132841</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen JM, Carter MJ, Cheung CR, et al. Lower risk of multisystem inflammatory syndrome in children (MIS-C) with the Delta and Omicron variants of SARS-CoV-2. Clin Infect Dis Official Publ Infect Dis Soc Am. 2022;76:ciac553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9278259</ArticleId><ArticleId IdType="pubmed">35788276</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole LD, Slate M, Minneman S, Bozzella MJ. Early release&#x2014;multisystem inflammatory syndrome after breakthrough SARS-CoV-2 infection in 2 immunized adolescents, united states&#x2014;volume 28, Number 7&#x2014;July 2022&#x2014;emerging infectious diseases Journal&#x2014;CDC. Emerg Infect Dis. 2022;28:1456&#x2013;1459. doi: 10.3201/eid2807.220560.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2807.220560</ArticleId><ArticleId IdType="pmc">PMC9239862</ArticleId><ArticleId IdType="pubmed">35642468</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio CR, Cotugno N, Sardh F, et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020;183:968&#x2013;981.e7. doi: 10.1016/j.cell.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7474869</ArticleId><ArticleId IdType="pubmed">32966765</ArticleId></ArticleIdList></Reference><Reference><Citation>Cron RQ. Biologic disease-modifying antirheumatic drugs to treat multisystem inflammatory syndrome in children. Curr Opin Rheumatol. 2022;34:274&#x2013;279. doi: 10.1097/bor.0000000000000889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/bor.0000000000000889</ArticleId><ArticleId IdType="pubmed">35791863</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao B, Wang C, Tan Y, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19) Front Immunol. 2020;11:827. doi: 10.3389/fimmu.2020.00827.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00827</ArticleId><ArticleId IdType="pmc">PMC7205903</ArticleId><ArticleId IdType="pubmed">32425950</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding J, Hostallero DE, Khili MRE, et al. A network-informed analysis of SARS-CoV-2 and hemophagocytic lymphohistiocytosis genes&#x2019; interactions points to Neutrophil extracellular traps as mediators of thrombosis in COVID-19. Plos Comput Biol. 2021;17:e1008810. doi: 10.1371/journal.pcbi.1008810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1008810</ArticleId><ArticleId IdType="pmc">PMC7971900</ArticleId><ArticleId IdType="pubmed">33684134</ArticleId></ArticleIdList></Reference><Reference><Citation>Du W, Yu J, Liu X, et al. Persistence of SARS-CoV-2 virus RNA in feces: a case series of children. J Infect Public Heal. 2020;13:926&#x2013;931. doi: 10.1016/j.jiph.2020.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.05.025</ArticleId><ArticleId IdType="pmc">PMC7275988</ArticleId><ArticleId IdType="pubmed">32546439</ArticleId></ArticleIdList></Reference><Reference><Citation>Eloseily EM, Weiser P, Crayne CB, et al. Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis. Arthritis Rheumatol. 2020;72:326&#x2013;334. doi: 10.1002/art.41103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41103</ArticleId><ArticleId IdType="pubmed">31513353</ArticleId></ArticleIdList></Reference><Reference><Citation>Fage C, H&#xe9;naut M, Carbonneau J, et al. Influenza A(H1N1)pdm09 virus but not respiratory syncytial virus interferes with SARS-CoV-2 replication during sequential infections in human nasal epithelial cells. Viruses. 2022;14:395. doi: 10.3390/v14020395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14020395</ArticleId><ArticleId IdType="pmc">PMC8879759</ArticleId><ArticleId IdType="pubmed">35215988</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. New Engl J Med. 2020;383:334&#x2013;346. doi: 10.1056/nejmoa2021680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2021680</ArticleId><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest CB, Burrows EK, Mejias A, et al. Severity of acute COVID-19 in children 18 years old march 2020 to December 2021. Pediatrics. 2022 doi: 10.1542/peds.2021-055765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-055765</ArticleId><ArticleId IdType="pubmed">35322270</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P, Kang L-Y, Liu J, Liu M. Immunogenicity, effectiveness, and safety of COVID-19 vaccines among children and adolescents aged 2&#x2013;18 years: an updated systematic review and meta-analysis. World J Pediatr. 2023 doi: 10.1007/s12519-022-00680-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-022-00680-9</ArticleId><ArticleId IdType="pmc">PMC9890438</ArticleId><ArticleId IdType="pubmed">36723827</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh P, Katkar GD, Shimizu C, et al. An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease. Nat Commun. 2022;13:2687. doi: 10.1038/s41467-022-30357-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30357-w</ArticleId><ArticleId IdType="pmc">PMC9110726</ArticleId><ArticleId IdType="pubmed">35577777</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber CN, Patel RS, Trachtman R, et al. mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C) Cell. 2020;183:982&#x2013;995.e14. doi: 10.1016/j.cell.2020.09.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.034</ArticleId><ArticleId IdType="pmc">PMC7489877</ArticleId><ArticleId IdType="pubmed">32991843</ArticleId></ArticleIdList></Reference><Reference><Citation>Han MS, Choi EH, Chang SH, et al. Clinical characteristics and viral RNA detection in children with coronavirus disease 2019 in the Republic of Korea. Jama Pediatr. 2021;175:73&#x2013;80. doi: 10.1001/jamapediatrics.2020.3988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2020.3988</ArticleId><ArticleId IdType="pmc">PMC7455883</ArticleId><ArticleId IdType="pubmed">32857112</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan A, Al-Ozairi E, Al-Baqsumi Z, et al. Cellular and humoral immune responses in covid-19 and immunotherapeutic approaches. Immunotargets Ther. 2021;10:63&#x2013;85. doi: 10.2147/itt.s280706.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/itt.s280706</ArticleId><ArticleId IdType="pmc">PMC7955763</ArticleId><ArticleId IdType="pubmed">33728277</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste L, researchers M-C, Soriano-Arandes A, , et al. Severe acute respiratory syndrome coronavirus 2 vaccination in children with a history of multisystem inflammatory syndrome in children: an international survey. J Pediatrics. 2022;248:114&#x2013;118. doi: 10.1016/j.jpeds.2022.05.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2022.05.028</ArticleId><ArticleId IdType="pmc">PMC9119291</ArticleId><ArticleId IdType="pubmed">35598642</ArticleId></ArticleIdList></Reference><Reference><Citation>Howe HL, Amarin JZ, Hayek H, et al. Safety and Immunogenicity of SARS-CoV-2 vaccination in children with a history of MIS-C. Open Forum Infect Dis. 2022 doi: 10.1093/ofid/ofac492.637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac492.637</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenney PO, Chang A, Krabill L, Hicar M. Decreased clinical severity of pediatric acute COVID-19 and MIS-C and increase of incidental cases during the omicron wave in comparison to the delta wave. Viruses. 2023 doi: 10.3390/v15010180.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15010180</ArticleId><ArticleId IdType="pmc">PMC9863387</ArticleId><ArticleId IdType="pubmed">36680220</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanmohammadi S, Rezaei N, Khazaei M, Shirkani A. A case of autosomal recessive interferon alpha/beta receptor alpha chain (IFNAR1) deficiency with severe COVID-19. J Clin Immunol. 2021;42:19&#x2013;24. doi: 10.1007/s10875-021-01166-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01166-5</ArticleId><ArticleId IdType="pmc">PMC8553400</ArticleId><ArticleId IdType="pubmed">34713375</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein N, Stockwell M, Demarco M, et al. Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19&#x2013;associated emergency department and urgent care encounters and hospitalizations among nonimmunocompromised children and adolescents aged 5&#x2013;17 Years&#x2014;VISION Network, 10 States, April 2021&#x2013;January 2022. MMWR Morbidity Mortality Weekly Report. 2022 doi: 10.1585/mmwr.mm7109e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1585/mmwr.mm7109e3</ArticleId><ArticleId IdType="pmc">PMC8893336</ArticleId><ArticleId IdType="pubmed">35239634</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumrah R, Vignesh P, Rawat A, Singh S. Immunogenetics of Kawasaki disease. Clin Rev Allerg Immu. 2020;59:122&#x2013;139. doi: 10.1007/s12016-020-08783-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-020-08783-9</ArticleId><ArticleId IdType="pubmed">32200494</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy N, Koppel JH, Kaplan O, et al. Severity and incidence of multisystem inflammatory syndrome in children during 3 SARS-CoV-2 pandemic waves in Israel. JAMA. 2022 doi: 10.1001/jama.2022.8025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.8025</ArticleId><ArticleId IdType="pmc">PMC9121298</ArticleId><ArticleId IdType="pubmed">35588048</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim L, Lim SJ, Loy JS, Ng DC. Multisystem inflammatory syndrome in children (MIS-C) occurring in temporal proximity between siblings. Bmj Case Reports. 2021;14:246066. doi: 10.1136/bcr-2021-246066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-246066</ArticleId><ArticleId IdType="pmc">PMC8449949</ArticleId><ArticleId IdType="pubmed">34531241</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo MS. A framework for understanding Kawasaki disease pathogenesis. Clin Immunol. 2020;214:108385. doi: 10.1016/j.clim.2020.108385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108385</ArticleId><ArticleId IdType="pubmed">32173601</ArticleId></ArticleIdList></Reference><Reference><Citation>Loske J, R&#xf6;hmel J, Lukassen S, et al. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children. Nat Biotechnol. 2021;40:319&#x2013;324. doi: 10.1038/s41587-021-01037-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-021-01037-9</ArticleId><ArticleId IdType="pubmed">34408314</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H, Liu D, Liu W, et al. Germline variants in UNC13D and AP3B1 are enriched in COVID-19 patients experiencing severe cytokine storms. Eur J Hum Genet. 2021;29:1312&#x2013;1315. doi: 10.1038/s41431-021-00886-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-021-00886-x</ArticleId><ArticleId IdType="pmc">PMC8053565</ArticleId><ArticleId IdType="pubmed">33867526</ArticleId></ArticleIdList></Reference><Reference><Citation>Malle L, Bastard P, Mart&#xed;n-Nalda A, et al. Atypical inflammatory syndrome triggered by SARS-CoV-2 in infants with down syndrome. J Clin Immunol. 2021;41:1457&#x2013;1462. doi: 10.1007/s10875-021-01078-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01078-4</ArticleId><ArticleId IdType="pmc">PMC8178650</ArticleId><ArticleId IdType="pubmed">34089457</ArticleId></ArticleIdList></Reference><Reference><Citation>Marks KJ, Whitaker M, Anglin O, et al. Hospitalizations of children and adolescents with laboratory-confirmed COVID-19 &#x2014; COVID-NET, 14 States, July 2021&#x2013;January 2022. Morbidity Mortal Wkly Rep. 2022;71:271&#x2013;278. doi: 10.1585/mmwr.mm7107e4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1585/mmwr.mm7107e4</ArticleId><ArticleId IdType="pmc">PMC8853476</ArticleId><ArticleId IdType="pubmed">35176003</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew D, Giles JR, Baxter AE, et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020;369:eabc8511. doi: 10.1126/science.abc8511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc8511</ArticleId><ArticleId IdType="pmc">PMC7402624</ArticleId><ArticleId IdType="pubmed">32669297</ArticleId></ArticleIdList></Reference><Reference><Citation>Matuozzo D, Talouarn E, Marchal A, et al. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with critical COVID-19. medRxiv. 2022 doi: 10.1101/2022.10.22.22281221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.10.22.22281221</ArticleId><ArticleId IdType="pmc">PMC9628204</ArticleId><ArticleId IdType="pubmed">36324795</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D, Ramanan AV, Bridgewood C. Immune cartography of macrophage activation syndrome in the COVID-19 era. Nat Rev Rheumatol. 2021;17:145&#x2013;157. doi: 10.1038/s41584-020-00571-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-00571-1</ArticleId><ArticleId IdType="pmc">PMC7863615</ArticleId><ArticleId IdType="pubmed">33547426</ArticleId></ArticleIdList></Reference><Reference><Citation>Meisel C, Akbil B, Meyer TW, et al. Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1. J Clin Invest. 2021 doi: 10.1172/jci150867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci150867</ArticleId><ArticleId IdType="pmc">PMC8279584</ArticleId><ArticleId IdType="pubmed">34061776</ArticleId></ArticleIdList></Reference><Reference><Citation>Middelburg JG, Crijnen TEM, D&#x2019;Antiga L, et al. Association of ethnicity with multisystem inflammatory syndrome in children related to SARS-CoV-2 infection: an international case-referent study. Frontiers Pediatrics. 2021;9:707650. doi: 10.3389/fped.2021.707650.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.707650</ArticleId><ArticleId IdType="pmc">PMC8555018</ArticleId><ArticleId IdType="pubmed">34722416</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller AD, Yousaf AR, Bornstein E, et al. multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 delta and omicron variant circulation&#x2014;United States, July 2021&#x2014;January 2022. Clin Infect Dis Official Publ Infect Dis Soc Am. 2022;75:ciac471. doi: 10.1093/cid/ciac471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac471</ArticleId><ArticleId IdType="pmc">PMC9214171</ArticleId><ArticleId IdType="pubmed">35684958</ArticleId></ArticleIdList></Reference><Reference><Citation>Minoia F, Lucioni F, Heshin-Bekenstein M, et al. Approaches to SARS-CoV-2 and other vaccinations in children with a history of multisystem inflammatory syndrome (MIS-C): An international survey. Frontiers Pediatrics. 2022;10:1030083. doi: 10.3389/fped.2022.1030083.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.1030083</ArticleId><ArticleId IdType="pmc">PMC9682234</ArticleId><ArticleId IdType="pubmed">36440337</ArticleId></ArticleIdList></Reference><Reference><Citation>Moga E, Lynton-Pons E, Domingo P. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection. Front Immunol. 2022;13:904686. doi: 10.3389/fimmu.2022.904686.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.904686</ArticleId><ArticleId IdType="pmc">PMC9271749</ArticleId><ArticleId IdType="pubmed">35833134</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreews M, Gouge KL, Khaldi-Plassart S, et al. Polyclonal expansion of TCR Vb 21 3+ CD4+ and CD8+ T cells is a hallmark of multisystem inflammatory syndrome in children. Sci Immunol. 2021;6:1516. doi: 10.1126/sciimmunol.abh1516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abh1516</ArticleId><ArticleId IdType="pmc">PMC8815705</ArticleId><ArticleId IdType="pubmed">34035116</ArticleId></ArticleIdList></Reference><Reference><Citation>Namkoong H, Edahiro R, Takano T, et al. DOCK2 is involved in the host genetics and biology of severe COVID-19. Nature. 2022;609:754&#x2013;760. doi: 10.1038/s41586-022-05163-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05163-5</ArticleId><ArticleId IdType="pmc">PMC9492544</ArticleId><ArticleId IdType="pubmed">35940203</ArticleId></ArticleIdList></Reference><Reference><Citation>Onouchi Y, Ozaki K, Burns JC, et al. A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet. 2012;44:517&#x2013;521. doi: 10.1038/ng.2220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2220</ArticleId><ArticleId IdType="pubmed">22446962</ArticleId></ArticleIdList></Reference><Reference><Citation>Onouchi Y, Fukazawa R, Yamamura K, et al. Variations in ORAI1 gene associated with Kawasaki disease. Plos One. 2016;11:e0145486. doi: 10.1371/journal.pone.0145486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0145486</ArticleId><ArticleId IdType="pmc">PMC4720480</ArticleId><ArticleId IdType="pubmed">26789410</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouldali N, Bagheri H, Salvo F, et al. Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: a national post-authorization pharmacovigilance study. Lancet Regional Heal - Europe. 2022;17:100393. doi: 10.1016/j.lanepe.2022.100393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100393</ArticleId><ArticleId IdType="pmc">PMC9051933</ArticleId><ArticleId IdType="pubmed">35505833</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer S, Cunniffe N, Donnelly R. COVID-19 hospitalization rates rise exponentially with age, inversely proportional to thymic T-cell production. J Roy Soc Interface. 2021;18:20200982. doi: 10.1098/rsif.2020.0982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2020.0982</ArticleId><ArticleId IdType="pmc">PMC8086881</ArticleId><ArticleId IdType="pubmed">33726544</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrino R, Chiappini E, Licari A, et al. Prevalence and clinical presentation of long COVID in children: a systematic review. Eur J Pediatr. 2022;181:3995&#x2013;4009. doi: 10.1007/s00431-022-04600-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04600-x</ArticleId><ArticleId IdType="pmc">PMC9476461</ArticleId><ArticleId IdType="pubmed">36107254</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce CA, Sy S, Galen B, et al. Natural mucosal barriers and COVID-19 in children. Jci Insight. 2021;6:148694. doi: 10.1172/jci.insight.148694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.148694</ArticleId><ArticleId IdType="pmc">PMC8262299</ArticleId><ArticleId IdType="pubmed">33822777</ArticleId></ArticleIdList></Reference><Reference><Citation>Piret J, Boivin G. Viral interference between respiratory viruses&#x2014;volume 28, number 2&#x2014;February 2022 - emerging infectious diseases journal&#x2014;CDC. Emerg Infect Dis. 2022;28:273&#x2013;281. doi: 10.3201/eid2802.211727.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2802.211727</ArticleId><ArticleId IdType="pmc">PMC8798701</ArticleId><ArticleId IdType="pubmed">35075991</ArticleId></ArticleIdList></Reference><Reference><Citation>Porritt RA, Binek A, Paschold L, et al. The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children. J Clin Invest. 2021 doi: 10.1172/jci151520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci151520</ArticleId><ArticleId IdType="pmc">PMC8516454</ArticleId><ArticleId IdType="pubmed">34437303</ArticleId></ArticleIdList></Reference><Reference><Citation>Porritt RA, Paschold L, Rivas MN, et al. HLA class I-associated expansion of TRBV11&#x2013;2 T cells in multisystem inflammatory syndrome in children. J Clin Invest. 2021 doi: 10.1172/jci146614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci146614</ArticleId><ArticleId IdType="pmc">PMC8121516</ArticleId><ArticleId IdType="pubmed">33705359</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaswamy A, Brodsky NN, Sumida TS, et al. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children. Immunity. 2021;54:1083&#x2013;1095.e7. doi: 10.1016/j.immuni.2021.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.04.003</ArticleId><ArticleId IdType="pmc">PMC8043654</ArticleId><ArticleId IdType="pubmed">33891889</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivas MN, Porritt RA, Cheng MH, et al. COVID-19&#x2013;associated multisystem inflammatory syndrome in children (MIS-C): a novel disease that mimics toxic shock syndrome&#x2014;the superantigen hypothesis. J Allergy Clin Immun. 2021;147:57&#x2013;59. doi: 10.1016/j.jaci.2020.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.10.008</ArticleId><ArticleId IdType="pmc">PMC7564502</ArticleId><ArticleId IdType="pubmed">33075409</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivas MN, Porritt RA, Cheng MH, et al. Multisystem inflammatory syndrome in children and Long COVID: The SARS-CoV-2 viral superantigen hypothesis. Front Immunol. 2022;13:941009. doi: 10.3389/fimmu.2022.941009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.941009</ArticleId><ArticleId IdType="pmc">PMC9300823</ArticleId><ArticleId IdType="pubmed">35874696</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Smith JJ, Verweyen EL, Clay GM, et al. Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study. Lancet Rheumatology. 2021;3:e574&#x2013;e584. doi: 10.1016/s2665-9913(21)00139-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2665-9913(21)00139-9</ArticleId><ArticleId IdType="pmc">PMC8186852</ArticleId><ArticleId IdType="pubmed">34124694</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronit A, J&#xf8;rgensen SE, Roed C, et al. Host genetics and antiviral immune responses in adult patients with multisystem inflammatory syndrome. Front Immunol. 2021;12:718744. doi: 10.3389/fimmu.2021.718744.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.718744</ArticleId><ArticleId IdType="pmc">PMC8439578</ArticleId><ArticleId IdType="pubmed">34531865</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosene KA, Copass MK, Kastner LS, et al. Persistent neuropsychological sequelae of toxic shock syndrome. Ann Intern Med. 1982;96:865. doi: 10.7326/0003-4819-96-6-865.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-96-6-865</ArticleId><ArticleId IdType="pubmed">7091958</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacco K, Castagnoli R, Vakkilainen S, et al. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19. Nat Med. 2022;28:1050&#x2013;1062. doi: 10.1038/s41591-022-01724-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01724-3</ArticleId><ArticleId IdType="pmc">PMC9119950</ArticleId><ArticleId IdType="pubmed">35177862</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos MO, Gon&#xe7;alves LC, Silva PAN, et al. Multisystem inflammatory syndrome (MIS-C): a systematic review and meta-analysis of clinical characteristics, treatment, and outcomes. J Pediat. 2021 doi: 10.1016/j.jped.2021.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jped.2021.08.006</ArticleId><ArticleId IdType="pmc">PMC9432310</ArticleId><ArticleId IdType="pubmed">34863701</ArticleId></ArticleIdList></Reference><Reference><Citation>Schimke LF, Marques AHC, Baiocchi GC, et al. Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states. Cells. 2022;11:847. doi: 10.3390/cells11050847.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11050847</ArticleId><ArticleId IdType="pmc">PMC8909161</ArticleId><ArticleId IdType="pubmed">35269470</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt A, Peters S, Knaus A, et al. TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19. Npj Genom Med. 2021;6:55. doi: 10.1038/s41525-021-00220-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41525-021-00220-w</ArticleId><ArticleId IdType="pmc">PMC8249618</ArticleId><ArticleId IdType="pubmed">34210994</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulert GS, Blum SA, Cron RQ. Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children. Curr Opin Pediatr. 2021;33:549&#x2013;555. doi: 10.1097/mop.0000000000001061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mop.0000000000001061</ArticleId><ArticleId IdType="pmc">PMC8571059</ArticleId><ArticleId IdType="pubmed">34534994</ArticleId></ArticleIdList></Reference><Reference><Citation>Sefik E, Qu R, Junqueira C, et al. Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature. 2022;606:585&#x2013;593. doi: 10.1038/s41586-022-04802-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04802-1</ArticleId><ArticleId IdType="pmc">PMC9288243</ArticleId><ArticleId IdType="pubmed">35483404</ArticleId></ArticleIdList></Reference><Reference><Citation>Shane AL, Sato AI, Kao C, et al. A pediatric infectious disease perspective of SARS-CoV-2 and COVID-19 in Children. J Pediatric Infect Dis Soc. 2020 doi: 10.1093/jpids/piaa099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piaa099</ArticleId><ArticleId IdType="pmc">PMC7499621</ArticleId><ArticleId IdType="pubmed">32840614</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw ER, Rosen LB, Cheng A, et al. Temporal dynamics of anti-type 1 interferon autoantibodies in patients with coronavirus disease 2019. Clin Infect Dis Official Publ Infect Dis Soc Am. 2021;75:e1192&#x2013;e1194. doi: 10.1093/cid/ciab1002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab1002</ArticleId><ArticleId IdType="pmc">PMC8689695</ArticleId><ArticleId IdType="pubmed">34875033</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi D, Whitaker M, Marks KJ, et al. Hospitalizations of children aged 5&#x2013;11 years with laboratory-confirmed COVID-19&#x2014;COVID-NET, 14 States, March 2020&#x2013;February 2022. Morbidity Mortal Wkly Rep. 2022;71:574&#x2013;581. doi: 10.1585/mmwr.mm7116e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1585/mmwr.mm7116e1</ArticleId><ArticleId IdType="pmc">PMC9042359</ArticleId><ArticleId IdType="pubmed">35446827</ArticleId></ArticleIdList></Reference><Reference><Citation>Shingleton J, Williams H, Oligbu G, et al. The changing epidemiology of PIMS-TS across COVID-19 waves: prospective national surveillance, January 2021 to July 2022, England. J Infection. 2022;85:702&#x2013;769. doi: 10.1016/j.jinf.2022.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.10.017</ArticleId><ArticleId IdType="pmc">PMC9583625</ArticleId><ArticleId IdType="pubmed">36273638</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K, Jamil R, Chowdhury A, et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. European Respir J. 2022;61:2200970. doi: 10.1183/13993003.00970-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorg A-L, Hufnagel M, Doenhardt M, et al. Risk for severe outcomes of COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany. Eur J Pediatr. 2022;181:3635&#x2013;3643. doi: 10.1007/s00431-022-04587-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04587-5</ArticleId><ArticleId IdType="pmc">PMC9374569</ArticleId><ArticleId IdType="pubmed">35962242</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorg AL, Sch&#xf6;nfeld V, Siedler A, et al. SARS-CoV-2 variants and the risk of pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 among children in Germany. Infection. 2022 doi: 10.1007/s15010-022-01908-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01908-6</ArticleId><ArticleId IdType="pmc">PMC9435410</ArticleId><ArticleId IdType="pubmed">36048361</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/s1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Stierman B, Abrams JY, Godfred-Cato SE, et al. Racial and ethnic disparities in multisystem inflammatory syndrome in children in the United States, March 2020 to February 2021. Pediatric Infect Dis J. 2021;40:e400&#x2013;e406. doi: 10.1097/inf.0000000000003294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/inf.0000000000003294</ArticleId><ArticleId IdType="pmc">PMC8505134</ArticleId><ArticleId IdType="pubmed">34382615</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Swadling L, Diniz MO, Schmidt NM, et al. Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2. Nature. 2021;601:110&#x2013;117. doi: 10.1038/s41586-021-04186-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04186-8</ArticleId><ArticleId IdType="pmc">PMC8732273</ArticleId><ArticleId IdType="pubmed">34758478</ArticleId></ArticleIdList></Reference><Reference><Citation>Szekanecz Z, Balog A, Constantin T, et al. COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients. Expert Rev Mol Med. 2022;24:e13. doi: 10.1017/erm.2022.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/erm.2022.10</ArticleId><ArticleId IdType="pmc">PMC8943223</ArticleId><ArticleId IdType="pubmed">35311631</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan SHX, Cook AR, Heng D, et al. Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age. New Engl J Med. 2022;387:525&#x2013;532. doi: 10.1056/nejmoa2203209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2203209</ArticleId><ArticleId IdType="pmc">PMC9342421</ArticleId><ArticleId IdType="pubmed">35857701</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J, Novak T, Hecker J, et al. Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C. Nat Commun. 2022;13:2979. doi: 10.1038/s41467-022-30649-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30649-1</ArticleId><ArticleId IdType="pmc">PMC9142524</ArticleId><ArticleId IdType="pubmed">35624101</ArticleId></ArticleIdList></Reference><Reference><Citation>Vagrecha A, Zhang M, Acharya S, et al. Hemophagocytic lymphohistiocytosis gene variants in multisystem inflammatory syndrome in children. Biology. 2022;11:417. doi: 10.3390/biology11030417.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology11030417</ArticleId><ArticleId IdType="pmc">PMC8945334</ArticleId><ArticleId IdType="pubmed">35336791</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Wijst MGP, Vazquez SE, Hartoularos GC, et al. Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19. Sci Transl Med. 2021;13:eabh2624. doi: 10.1126/scitranslmed.abh2624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abh2624</ArticleId><ArticleId IdType="pmc">PMC8601717</ArticleId><ArticleId IdType="pubmed">34429372</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Nie J, Wang H, et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J Infect Dis. 2020;221:150. doi: 10.1093/infdis/jiaa150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa150</ArticleId><ArticleId IdType="pmc">PMC7184346</ArticleId><ArticleId IdType="pubmed">32227123</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Berger NA, Kaelber DC, et al. Incidence rates and clinical outcomes of SARS-CoV-2 infection with the omicron and delta variants in children younger than 5 Years in the US. Jama Pediatr. 2022;176:811&#x2013;813. doi: 10.1001/jamapediatrics.2022.0945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.0945</ArticleId><ArticleId IdType="pmc">PMC8976262</ArticleId><ArticleId IdType="pubmed">35363246</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker E, Bamford A, Kenny J, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324:259&#x2013;269. doi: 10.1001/jama.2020.10369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.10369</ArticleId><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker R, Greve-Isdahl M, B&#xf8;&#xe5;s H, et al (2022) COVID-19 Hospitalization Among Children &lt;18 Years by Variant Wave in Norway. Pediatrics 150:. 10.1542/peds.2022-057564</Citation><ArticleIdList><ArticleId IdType="pubmed">35916036</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X, Shi X, Liu M. The roles of genetic factors in kawasaki disease: a systematic review and meta-analysis of genetic association studies. Pediatr Cardiol. 2018;39:207&#x2013;225. doi: 10.1007/s00246-017-1760-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-017-1760-0</ArticleId><ArticleId IdType="pubmed">29098351</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Li X, Zhu B, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020;26:502&#x2013;505. doi: 10.1038/s41591-020-0817-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0817-4</ArticleId><ArticleId IdType="pmc">PMC7095102</ArticleId><ArticleId IdType="pubmed">32284613</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M. Cell pyroptosis, a potential pathogenic mechanism of 2019-nCoV infection. Ssrn Electron J. 2020 doi: 10.2139/ssrn.3527420.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3527420</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker LM, Gilboa T, Ogata AF, et al. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J Clin Invest. 2021 doi: 10.1172/jci149633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci149633</ArticleId><ArticleId IdType="pmc">PMC8279585</ArticleId><ArticleId IdType="pubmed">34032635</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida M, Worlock KB, Huang N, et al. Local and systemic responses to SARS-CoV-2 infection in children and adults. Nature. 2021;602:321&#x2013;327. doi: 10.1038/s41586-021-04345-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04345-x</ArticleId><ArticleId IdType="pmc">PMC8828466</ArticleId><ArticleId IdType="pubmed">34937051</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousaf AR, Cortese MM, Taylor AW, et al. Reported cases of multisystem inflammatory syndrome in children aged 12&#x2013;20 years in the USA who received a COVID-19 vaccine, December 2020, through August, 2021: a surveillance investigation. Lancet Child Adolesc Heal. 2022;6:303&#x2013;312. doi: 10.1016/s2352-4642(22)00028-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2352-4642(22)00028-1</ArticleId><ArticleId IdType="pmc">PMC8864018</ArticleId><ArticleId IdType="pubmed">35216660</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambrano LD, Newhams MM, Olson SM, et al. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12&#x2013;18 years&#x2014;United States july&#x2013;december 2021. Morbidity Mortal Wkly Rep. 2022;71:52&#x2013;58. doi: 10.15585/mmwr.mm7102e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7102e1</ArticleId><ArticleId IdType="pmc">PMC8757620</ArticleId><ArticleId IdType="pubmed">35025852</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Bastard P, Bolze A, et al. Life-threatening COVID-19: defective interferons unleash excessive inflammation. Med. 2020;1:14&#x2013;20. doi: 10.1016/j.medj.2020.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2020.12.001</ArticleId><ArticleId IdType="pmc">PMC7748410</ArticleId><ArticleId IdType="pubmed">33363283</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Bastard P, Effort CHG, et al. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature. 2022;603:587&#x2013;598. doi: 10.1038/s41586-022-04447-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04447-0</ArticleId><ArticleId IdType="pmc">PMC8957595</ArticleId><ArticleId IdType="pubmed">35090163</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Matuozzo D, Pen JL, et al. Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia. J Exp Med. 2022;219:e20220131. doi: 10.1084/jem.20220131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20220131</ArticleId><ArticleId IdType="pmc">PMC9206114</ArticleId><ArticleId IdType="pubmed">35708626</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H-P, Sun Y-L, Wang Y-F, et al. Recent developments in the immunopathology of COVID-19. Allergy. 2023;78:369&#x2013;388. doi: 10.1111/all.15593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15593</ArticleId><ArticleId IdType="pmc">PMC10108124</ArticleId><ArticleId IdType="pubmed">36420736</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Chen W, Gong F, et al. The role and mechanism of pyroptosis and potential therapeutic targets in sepsis: a review. Front Immunol. 2021;12:711939. doi: 10.3389/fimmu.2021.711939.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.711939</ArticleId><ArticleId IdType="pmc">PMC8293747</ArticleId><ArticleId IdType="pubmed">34305952</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>